Pfizer Limited Profit Margin

The latest profit margin for PFIZER.NS is 28.61% as of June 2026. That compares with 34.83% in the prior-year period — down 17.9% year over year. That is above the sector sector average of 13.2%. Investors often review this figure alongside Pfizer Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, PFIZER.NS's profit margin moved from 34.83% to 28.61% — a 17.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pfizer Limited's valuation or profitability profile.

Against its sector companies, PFIZER.NS currently prints 28.61% for profit margin, while the sector average sits near 13.2%. That is roughly 116.7% above the sector mean. Large gaps often invite a closer look at Pfizer Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Pfizer Limited converts resources into returns. At 28.61%, PFIZER.NS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 34.83% in the prior-year period — down 17.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PFIZER.NS's profit margin (28.61%), review year-over-year change from 34.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.